In lieu of an abstract, here is a brief excerpt of the content:

formation in the community in the 1970s, as well as the role of African Americans in passing mandatory sickle cell screening laws—which led to discrimination by the Armed Forces, employees, schools, and insurance companies against persons with sickle cell trait. Today, however, we still have not learned from history. The University of California -Berkeley Lawrence Livermore Laboratory, supported by the Department ofEnergy (a cosponsor of this symposium and the Human Genome Program) was recently sued by employees of the Laboratory (Norman-Bloodsaw, et al. v. Lawrence Berkeley Laboratory, et al. 98 CD.O.S. 901, 1998) for a program that selectively screened African Americans for sickle hemoglobin and repeatedly tested only African Americans and Hispanics for syphilis, without their knowledge or consent— patent violations of the ethical guidelines of the NIH/Department of Energy Human Genome Program. Plain Talk about the Human Genome Project includes the following general sections, covering an exhaustive analysis of the Human Genome Program: The Promise, Matters of Race and Diversity, The Perils, Recapitulation, Education and the Human Genome Project, and Appendices. The distinguished speakers included more than 30 experts in the fields of molecular and medical genetics, genetic counseling, ethics and philosophy, community action, law, sociology, epidemiology, general medicine , preventive medicine, and education, as well as representatives of the NIH and the Department of Energy Human Genome Program. Students and consumers are also represented and introduce views not often considered by academicians. This book is for all of us, for, as was repeatedly pointed out by many speakers, we all will be affected by the Human Genome Program. When the human genome (s) are sequenced and loci for genetic variations, potential disease, and disease are identified, we will find that we all are at risk. This knowledge may be the best defense against genetic stigmatization and discrimination—a preeminent concern of the symposium—for we are all "imperfect." James E. Bowman, M.D. The University of Chicago Assisted Reproductive Technologies: Analysis and Recommendationsfor Public Policy. By New York State Task Force on Life and Law. Thank you, New York State Task Force on Life and the Law, for Assisted Reproductive Technologies: Analysis and Recommendations for Public Policy. Reproductive health care practitioners, attorneys, legal scholars, social scientists, policy analysts, and policymakers have long awaited a document of this sort. Some readers already may be familiar with the work of New York's interdisciplinary task force. In the past decade the group has published policy recommendations on assisted suicide, "do not resuscitate" status, surrogate parenting, and other ethically challenging medical and legal issues. Importantly, many Task Force recommendations later have been enacted in New York State law. Assisted Reproductive Technologies is the group's most recent publication. In this text, the Task Force explores the complicated clinical, legal, and ethical dimensions ofin vitro fertilization, gamete and embryo donation, and cloning, as well as issues that naturally spring 454 Book Reviews from these infertility technologies, such as informed consent and parental rights and responsibilities. The Task Force recommends several dozen legislative and regulatory initiatives. Readers pressed for time can easily and quickly digest the 400-page document's important points by perusing the opening "executive summary" and closing legislative recommendations. The intervening text, however, is well organized and well researched and deserves attention. The text presents a thorough review of the most recent infertility and infertility treatment literature in obstetrics, gynecology, and reproductive endocrinology. This material will be helpful to medical practitioners craving a critical synthesis of assisted reproduction technology (ART) literature, and to non-medical readers who need to get quickly up to speed in the field. The text very nicely explores multiple religious perspectives, as well as a wide range of patient perspectives on ART. It includes extensive discussion of issues in gamete donation, storage, and disposition, including the difficult situations of death or divorce of gamete provides. It provides a reasonable summary of feminist perspectives on infertility technology. Its discussions of patient selection, parenting issues, rights of future children, and commercial aspects ofART are particular good. The Task Force does not discuss details of its methodology, other than to note that it "solicited in put from a broad range ofindividuals interested in the field...

pdf

Share